BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Introduction of a patient alert card for medicinal products containing valproate and related substances

Active substance: valproate and related substances

In a notice dated 10 April 2017, the Federal Institute for Drugs and Medical Devices (BfArM) ruled the introduction of a patient alert card for medicinal products containing valproate as a supplementary risk minimisation measure. The companies concerned have issued a corresponding information letter.

information letter - full text (available in German only)


Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK